Current landscape of fecal microbiota transplantation in treating depression
Qi Zhang,
No information about this author
Yajun Bi,
No information about this author
Boyu Zhang
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: June 25, 2024
Depression,
projected
to
be
the
predominant
contributor
global
disease
burden,
is
a
complex
condition
with
diverse
symptoms
including
mood
disturbances
and
cognitive
impairments.
Traditional
treatments
such
as
medication
psychotherapy
often
fall
short,
prompting
pursuit
of
alternative
interventions.
Recent
research
has
highlighted
significant
role
gut
microbiota
in
mental
health,
influencing
emotional
neural
regulation.
Fecal
transplantation
(FMT),
infusion
fecal
matter
from
healthy
donor
into
patient,
emerges
promising
strategy
ameliorate
depressive
by
restoring
microbial
balance.
The
microbial-gut-brain
(MGB)
axis
represents
critical
pathway
through
which
potentially
rectify
dysbiosis
modulate
neuropsychiatric
outcomes.
Preclinical
studies
reveal
that
FMT
can
enhance
neurochemicals
reduce
inflammatory
markers,
thereby
alleviating
behaviors.
Moreover,
shown
promise
clinical
settings,
improving
gastrointestinal
overall
quality
life
patients
depression.
review
highlights
gut-brain
depression
need
for
further
validate
long-term
safety
efficacy
FMT,
identify
specific
therapeutic
strains,
develop
targeted
modulation
strategies.
Advancing
our
understanding
could
revolutionize
treatment,
shifting
paradigm
toward
microbiome-targeting
therapies.
Language: Английский
Trelagliptin Ameliorates Memory Decline in Diabetic Rats through the AMPK/AKT/GSK-3β Pathway in the Cerebral Cortex
Yue Yao,
No information about this author
Ting Shu,
No information about this author
Xiying Guo
No information about this author
et al.
ACS Omega,
Journal Year:
2025,
Volume and Issue:
10(15), P. 15673 - 15680
Published: April 11, 2025
Examining
how
hypoglycemic
medications
affect
brain
function
is
one
of
the
best
approaches
to
addressing
cognitive
impairment.
In
this
study,
trelagliptin,
a
dipeptidyl
peptidase-4
(DPP4)
inhibitor,
was
utilized
assess
memory
loss
in
diabetic
rats
through
fear
conditioning
tests.
Trelagliptin
restored
that
had
been
disrupted
over
relatively
long
period
(24
h)
or
extended
(5
days).
Moreover,
trelagliptin
treatment
reduced
higher
incidence
neuronal
cell
death
cerebral
cortex,
as
observed
via
Nissl
hematoxylin
and
eosin
staining.
Subsequent
analyses
revealed
exhibited
elevated
levels
inflammatory
cytokines
(p-IKKα
p-NFκB)
trend
toward
oxidative
damage,
indicated
by
malondialdehyde
(MDA),
superoxide
dismutase
2
(SOD2),
glutathione
peroxidase
4
(GPX4)
detection.
However,
administration
reversed
these
markers
baseline
levels.
Additionally,
activated
p-AMPK,
p-AKT,
p-GSK-3β.
Notably,
upregulated
expression
postsynaptic
density
protein
95
(PSD95)
synaptotagmin
1
(SYT1)
while
downregulating
amyloid
precursor
(APP)
beta-site
cleaving
enzyme
(BACE1).
These
findings
suggest
alleviates
impairment
rats,
likely
AMPK-AKT-GSK-3β-mediated
mitigation
stress,
enhancement
synaptic
plasticity,
reduction
Aβ
accumulation.
Language: Английский
Fecal microbiota transplantation alleviates cognitive impairment by improving gut microbiome composition and barrier function in male rats of traumatic brain injury following gas explosion
Xinwen Dong,
No information about this author
Yaguang Su,
No information about this author
Zheng Luo
No information about this author
et al.
Frontiers in Microbiology,
Journal Year:
2024,
Volume and Issue:
15
Published: Nov. 1, 2024
Dysbiosis
of
gut
microbiota
(GM)
is
intricately
linked
with
cognitive
impairment
and
the
incidence
traumatic
brain
injury
(TBI)
in
both
animal
models
human
subjects.
However,
there
limited
understanding
impact
mechanisms
fecal
transplantation
(FMT)
on
barrier
function
treatment
TBI
induced
by
gas
explosion
(GE).
We
have
employed
FMT
technology
to
establish
dysbiosis
male
rats,
subsequently
conducted
non-targeted
metabolomics
diversity
analysis
explore
bacteria
potential
functional
roles.
Hematoxylin-eosin
transmission
electron
microscopy
revealed
that
GE
significant
pathological
damage
inflammation
responses,
as
well
varying
degrees
mitochondrial
neuronal
cells
brains
which
was
associated
decline.
Furthermore,
markedly
elevated
levels
regulatory
T
cell
(Tregs)-related
factors
interleukin-10,
programmed
death
1,
fork
head
box
protein
P3
rats.
Similar
changes
these
indicators
were
also
observed
colon;
however,
alterations
reversed
upon
transfer
normal
flora
into
GE-exposed
Combined
microbiome
metabolome
indicated
up-regulation
Clostridium_T
Allobaculum,
along
activation
fatty
acid
biosynthesis
after
FMT.
Correlation
network
indirectly
suggested
a
causal
relationship
between
alleviation
GE-induced
TBI.
improved
intestinal
structure
up-regulated
expression
tight
junction
proteins
Claudin-1,
Occludin,
ZO-1,
potentially
contributing
its
protective
effects
gut.
Transplantation
from
healthy
rats
significantly
enhanced
caused
explosion,
through
modulation
composition
improvement
integrity
via
gut-brain
axis.
These
findings
may
offer
scientific
foundation
for
clinical
interventions
targeting
explosion-induced
using
Language: Английский
Efficacy of MSC-derived small extracellular vesicles in treating type II diabetic cutaneous wounds: a systematic review and meta-analysis of animal models
Guangren Yue,
No information about this author
Yu‐Chuan Li,
No information about this author
Zheng Liu
No information about this author
et al.
Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 15, 2024
Small
extracellular
vesicles
derived
from
mesenchymal
stem
cells
(MSC-sEVs)
have
emerged
as
a
promising
therapy
for
treating
type
II
diabetic
cutaneous
wounds.
Currently,
the
evidence
supporting
use
of
MSC-sEVs
skin
wounds
remains
inconclusive
and
is
limited
to
preclinical
studies.
To
facilitate
clinical
translation
cell-free
therapy,
conducting
comprehensive
systematic
review
studies
assessing
efficacy
imperative.
Language: Английский
Agonistes des récepteurs GLP-1 dans la maladie d’Alzheimer : Potentiel thérapeutique et mécanismes d’action
Benyaich Abdelhay,
No information about this author
Aksissou Mustapha,
No information about this author
Elkhattabi Lamiae
No information about this author
et al.
Médecine des Maladies Métaboliques,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 1, 2024
Modern views on pathogenesis of cognitive impairment in patients with type 2 diabetes mellitus
T. Yu. Demidova,
No information about this author
A. S. Teplova,
No information about this author
V. O. Yarmanova
No information about this author
et al.
Meditsinskiy sovet = Medical Council,
Journal Year:
2024,
Volume and Issue:
16, P. 265 - 273
Published: Nov. 1, 2024
Currently,
the
features
of
pathogenesis
cognitive
impairment
in
patients
with
diabetes
mellitus
are
being
actively
studied.
The
study
mutual
influence
these
pathologies
is
particular
relevant
not
only
connection
a
decrease
functions
mellitus,
but
also
due
to
fact
that
management
requires
thorough
approach
implementation
doctor’s
recommendations
and
self-control
on
part
patient
himself.
degree
has
direct
impact
compliance
and,
consequently,
control
disease.
A
comprehensive
strategy
necessary
for
prevention
progression
impairments
mellitus.
This
should
include
minimizing
modifiable
risk
factors,
controlling
comorbidities,
maintaining
healthy
lifestyle,
following
diet,
engaging
regular
physical
activity,
medication
therapy.
Also,
one
key
aspects
blood
glucose
levels.
Regular
monitoring
stable
level
sugar
can
significantly
reduce
developing
diabetic
patients.
review
analyzes
effects
oral
hypoglycemic
drugs,
incretin-based
therapy
insulin
impairments.
examines
important
role
pathogenetic
links
clinical
manifestations
type
2
development
possibility
influencing
their
rate
progression.
Understanding
relationships
will
help
develop
effective
strategies
treatment
Language: Английский